|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US6117643A
(en)
*
|
1997-11-25 |
2000-09-12 |
Ut Battelle, Llc |
Bioluminescent bioreporter integrated circuit
|
|
EP1154691A4
(en)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
TARGETED ADMINISTRATION OF REGULATED RELEASE MEDICINE TO RETINA AND CHOROID THROUGH SCLEROTIC
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
JP2003511204A
(ja)
|
1999-10-21 |
2003-03-25 |
アルコン，インコーポレイティド |
テノン下薬剤送出
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
CA2383499C
(en)
*
|
1999-10-21 |
2009-11-24 |
Alcon Universal Ltd. |
Drug delivery device
|
|
US6331313B1
(en)
*
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US20040115268A1
(en)
*
|
2000-04-26 |
2004-06-17 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
|
US20040170955A1
(en)
*
|
2000-09-08 |
2004-09-02 |
Wadih Arap |
Human and mouse targeting peptides identified by phage display
|
|
US7452964B2
(en)
*
|
2001-09-07 |
2008-11-18 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides against placenta and adipose tissues
|
|
US7420030B2
(en)
*
|
2000-09-08 |
2008-09-02 |
The Board Of Regents Of The University Of Texas System |
Aminopeptidase A (APA) targeting peptides for the treatment of cancer
|
|
US20050074747A1
(en)
*
|
2000-09-08 |
2005-04-07 |
Wadih Arap |
Biopanning and rapid analysis of selective interactive ligands (brasil)
|
|
WO2002036175A2
(en)
*
|
2000-11-03 |
2002-05-10 |
Control Delivery Systems |
Sustained release device for treating conditions of the joint
|
|
EP1339438B1
(en)
*
|
2000-11-29 |
2005-10-19 |
Allergan Inc. |
Preventing transplant rejection in the eye
|
|
JP2004517674A
(ja)
*
|
2000-12-29 |
2004-06-17 |
ボシュ・アンド・ロム・インコーポレイテッド |
徐放薬物送達装置
|
|
JP2004521882A
(ja)
*
|
2001-01-03 |
2004-07-22 |
ボシュ・アンド・ロム・インコーポレイテッド |
組立式透過性プラグを備えた徐放薬剤送達装置
|
|
US20020086051A1
(en)
*
|
2001-01-03 |
2002-07-04 |
Santos Viscasillas |
Sustained release drug delivery devices with coated drug cores
|
|
JP4184082B2
(ja)
|
2001-01-03 |
2008-11-19 |
ボシュ・アンド・ロム・インコーポレイテッド |
複数の薬剤を備えた徐放薬剤送達装置
|
|
EP1847255A3
(en)
*
|
2001-01-03 |
2009-03-04 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
|
WO2002058667A2
(en)
*
|
2001-01-26 |
2002-08-01 |
Bausch & Lomb Incorporated |
Improved process for the production of sustained release drug delivery devices
|
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
|
ES2331302T3
(es)
|
2001-05-01 |
2009-12-29 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Composiciones de hidrogel.
|
|
EP1390084B1
(en)
*
|
2001-05-01 |
2011-03-23 |
A.V. Topchiev Institute of Petrochemical Synthesis |
Two-phase, water-absorbent bioadhesive composition
|
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
|
US8541021B2
(en)
*
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
|
EP1387671A1
(en)
|
2001-05-03 |
2004-02-11 |
MASSACHUSETTS EYE & EAR INFIRMARY |
Implantable drug delivery device and use thereof
|
|
EP1404297B1
(en)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
|
EP1418932A4
(en)
*
|
2001-07-18 |
2006-03-15 |
Univ Texas |
ANTIANGIOGENIC CONDITION IN MICE AND PEOPLE WITH RETINAL PHOTOREEPEPTOR DEGENERATION
|
|
WO2003009774A2
(en)
|
2001-07-23 |
2003-02-06 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
|
AU2002319606B2
(en)
*
|
2001-07-23 |
2006-09-14 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
|
WO2003020172A1
(en)
|
2001-08-29 |
2003-03-13 |
De Carvalho Ricardo A P |
An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
|
|
US20040048243A1
(en)
*
|
2001-09-07 |
2004-03-11 |
Wadih Arap |
Methods and compositions for in vitro targeting
|
|
US8507445B2
(en)
*
|
2001-09-07 |
2013-08-13 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US7671010B2
(en)
*
|
2002-08-30 |
2010-03-02 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US20030158598A1
(en)
*
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
|
DK1469723T3
(da)
*
|
2002-01-31 |
2007-03-05 |
Disease Control Textiles Sa |
Lamineret insekticiddoseringsorgan
|
|
WO2003071986A2
(en)
*
|
2002-02-22 |
2003-09-04 |
Control Delivery Systems, Inc. |
Method for treating otic disorders
|
|
KR101173497B1
(ko)
*
|
2002-03-11 |
2012-08-14 |
알콘, 인코퍼레이티드 |
이식 가능한 약물 전달 시스템
|
|
EP1495120B1
(en)
*
|
2002-04-18 |
2012-10-10 |
Acuity Pharmaceuticals, Inc |
Means and methods for the specific modulation of target genes in the eye
|
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
|
WO2003092514A1
(en)
*
|
2002-05-02 |
2003-11-13 |
Control Delivery Systems, Inc. |
Device and method for treating conditions of a joint
|
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
BR0309844A
(pt)
*
|
2002-05-07 |
2005-02-15 |
Control Delivery Sys Inc |
Processos para formação de um dispositivo para a distribuição de droga
|
|
KR20060013632A
(ko)
|
2002-05-17 |
2006-02-13 |
오쎄라 파마슈티걸즈, 인크. |
백내장 및 다른 안질환 발병의 개선
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
ES2295647T3
(es)
|
2002-07-15 |
2008-04-16 |
Alcon, Inc. |
Composiciones de implante farmaceuticas lipofilas, no polimeras, para uso intraocular.
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
AU2003301347A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
|
WO2004043435A2
(en)
*
|
2002-11-13 |
2004-05-27 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
CA2453013C
(en)
*
|
2002-12-13 |
2011-02-15 |
Gary W. Cleary |
Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
|
|
AU2003301129A1
(en)
*
|
2002-12-20 |
2004-07-22 |
Control Delivery Systems, Inc. |
Steroid compositions for intraocular use
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
JP2007524349A
(ja)
|
2003-01-16 |
2007-08-30 |
ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア |
ＩＣＡＭ−１のｓｉＲＮＡ阻害のための組成物及び方法
|
|
MXPA05007717A
(es)
*
|
2003-01-24 |
2005-09-30 |
Control Delivery Sys Inc |
Liberacion controlada de agentes altamente solubles.
|
|
DK1592408T3
(da)
*
|
2003-01-24 |
2010-01-04 |
Psivida Inc |
Indretning med depotvirkning og fremgangsmåde til okulær indgivelse af adrenergt midler
|
|
KR20050108345A
(ko)
*
|
2003-01-24 |
2005-11-16 |
컨트롤 딜리버리 시스템즈 인코포레이티드 |
탄산 탈수효소 저해제의 안구 전달을 위한 서방 장치와방법
|
|
WO2004066939A2
(en)
*
|
2003-01-27 |
2004-08-12 |
Sarnoff Corporation |
Controlled-release drug delivery system
|
|
US20060167435A1
(en)
*
|
2003-02-18 |
2006-07-27 |
Adamis Anthony P |
Transscleral drug delivery device and related methods
|
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
|
US7561916B2
(en)
|
2005-06-24 |
2009-07-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with indicator
|
|
US8715243B2
(en)
*
|
2003-06-16 |
2014-05-06 |
Ethicon Endo-Surgery, Inc. |
Injection port applier with downward force actuation
|
|
US8007474B2
(en)
|
2003-06-16 |
2011-08-30 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with reversible attachment mechanism and method
|
|
US7862546B2
(en)
*
|
2003-06-16 |
2011-01-04 |
Ethicon Endo-Surgery, Inc. |
Subcutaneous self attaching injection port with integral moveable retention members
|
|
US8518390B2
(en)
|
2003-06-27 |
2013-08-27 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
|
|
WO2005001080A2
(en)
|
2003-06-27 |
2005-01-06 |
Ethicon, Incorporated |
Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
|
|
WO2006071794A2
(en)
|
2004-12-23 |
2006-07-06 |
Ethicon Incorporated |
Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
|
|
US9592258B2
(en)
|
2003-06-27 |
2017-03-14 |
DePuy Synthes Products, Inc. |
Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
|
|
US7875272B2
(en)
*
|
2003-06-27 |
2011-01-25 |
Ethicon, Incorporated |
Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
|
|
US9572840B2
(en)
|
2003-06-27 |
2017-02-21 |
DePuy Synthes Products, Inc. |
Regeneration and repair of neural tissue using postpartum-derived cells
|
|
US8790637B2
(en)
*
|
2003-06-27 |
2014-07-29 |
DePuy Synthes Products, LLC |
Repair and regeneration of ocular tissue using postpartum-derived cells
|
|
US8491883B2
(en)
*
|
2003-06-27 |
2013-07-23 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of amyotrophic lateral sclerosis using umbilical derived cells
|
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
EP1648363B1
(en)
*
|
2003-07-03 |
2019-03-06 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
|
|
KR20060082792A
(ko)
*
|
2003-07-10 |
2006-07-19 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
|
KR20060085246A
(ko)
*
|
2003-09-18 |
2006-07-26 |
마커사이트, 인코포레이티드 |
경공막 전달
|
|
NZ575950A
(en)
*
|
2003-11-13 |
2010-06-25 |
Psivida Inc |
Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
|
|
CA2546042A1
(en)
|
2003-11-20 |
2005-06-09 |
Othera Pharmaceuticals, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
US8162897B2
(en)
*
|
2003-12-19 |
2012-04-24 |
Ethicon Endo-Surgery, Inc. |
Audible and tactile feedback
|
|
US20050148948A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Caputa Steven G. |
Sutureless ophthalmic drug delivery system and method
|
|
DE10360185A1
(de)
*
|
2003-12-20 |
2005-08-04 |
Max Wyssmann |
Vorrichtung zur gezielten, steuerbaren Abgabe oder zum Ansaugen einer Flüssigkeit oder einer viskosen Masse
|
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
|
US20050158365A1
(en)
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
|
US20050137538A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20070053963A1
(en)
*
|
2004-01-13 |
2007-03-08 |
Hotchkiss Robert N |
Drug delivery to a joint
|
|
JP2007519724A
(ja)
*
|
2004-01-26 |
2007-07-19 |
シヴィダ・インコーポレイテッド |
核酸を基剤とする治療剤の制御送達および持続的送達
|
|
RU2380092C2
(ru)
|
2004-01-30 |
2010-01-27 |
Кориум Интернэшнл, Инк. |
Быстро растворяющаяся пленка для доставки активного агента
|
|
US20060018949A1
(en)
*
|
2004-04-07 |
2006-01-26 |
Bausch & Lomb Incorporated |
Injectable biodegradable drug delivery system
|
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
EA012668B1
(ru)
*
|
2004-05-25 |
2009-12-30 |
Отера Холдинг, Инк. |
Окулоселективные лекарственные средства и пролекарства
|
|
CA2572223C
(en)
|
2004-06-25 |
2014-08-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
|
US7922702B2
(en)
|
2004-07-02 |
2011-04-12 |
Qlt Inc. |
Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
|
|
WO2006014484A2
(en)
*
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
|
EP1791575B1
(en)
*
|
2004-08-05 |
2014-10-08 |
Corium International, Inc. |
Adhesive composition
|
|
US20060067978A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly(vinyl alcohol) drug delivery devices
|
|
US20060068012A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
|
|
WO2006039333A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
|
US20060067980A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
|
US20060078592A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Bausch & Lomb Incorporated |
Drug delivery systems
|
|
US20070276481A1
(en)
*
|
2004-12-08 |
2007-11-29 |
Renner Steven B |
Drug delivery device
|
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
|
US20060153815A1
(en)
*
|
2004-12-21 |
2006-07-13 |
Agnieszka Seyda |
Tissue engineering devices for the repair and regeneration of tissue
|
|
US20060171930A1
(en)
*
|
2004-12-21 |
2006-08-03 |
Agnieszka Seyda |
Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
|
|
US20060166361A1
(en)
*
|
2004-12-21 |
2006-07-27 |
Agnieszka Seyda |
Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
|
|
WO2006068898A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Bausch & Lomb Incorporated |
Reusable drug delivery device
|
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
|
WO2006071778A2
(en)
|
2004-12-23 |
2006-07-06 |
Ethicon Incorporated |
Treatment of parkinson's disease and related disorders using postpartum derived cells
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
DK1848431T3
(en)
*
|
2005-02-09 |
2016-04-18 |
Santen Pharmaceutical Co Ltd |
LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
|
|
AU2006227116A1
(en)
*
|
2005-03-21 |
2006-09-28 |
Santen Pharmaceutical Co., Ltd. |
Drug delivery systems for treatment of diseases or conditions
|
|
US8003124B2
(en)
*
|
2005-04-08 |
2011-08-23 |
Surmodics, Inc. |
Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease
|
|
US20080312283A1
(en)
*
|
2005-05-26 |
2008-12-18 |
Othera Pharmaceuticals, Inc. |
Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts
|
|
US7651483B2
(en)
*
|
2005-06-24 |
2010-01-26 |
Ethicon Endo-Surgery, Inc. |
Injection port
|
|
US7918844B2
(en)
|
2005-06-24 |
2011-04-05 |
Ethicon Endo-Surgery, Inc. |
Applier for implantable medical device
|
|
US20060292202A1
(en)
*
|
2005-06-27 |
2006-12-28 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20100004156A1
(en)
|
2005-07-27 |
2010-01-07 |
Shalesh Kaushal |
Small Compounds That Correct Protein Misfolding and Uses Thereof
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
EA016227B1
(ru)
|
2005-11-29 |
2012-03-30 |
Смитклайн Бичем Корпорейшн |
Способ лечения офтальмологических неоваскулярных расстройств
|
|
WO2007070870A1
(en)
*
|
2005-12-16 |
2007-06-21 |
Ethicon, Inc. |
Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
|
|
US9125906B2
(en)
|
2005-12-28 |
2015-09-08 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
|
|
WO2007076522A2
(en)
*
|
2005-12-28 |
2007-07-05 |
Ethicon, Incorporated |
Treatment of peripheral vascular disease using postpartum-derived cells
|
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
KR20140093764A
(ko)
|
2006-02-09 |
2014-07-28 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
ES2563288T3
(es)
|
2006-03-23 |
2016-03-14 |
Santen Pharmaceutical Co., Ltd |
Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
|
|
SG170816A1
(en)
|
2006-03-31 |
2011-05-30 |
Qlt Plug Delivery Inc |
Drug delivery methods, structures, and compositions for nasolacrimal system
|
|
US20090130212A1
(en)
*
|
2006-05-15 |
2009-05-21 |
Physical Pharmaceutica, Llc |
Composition and improved method for preparation of small particles
|
|
DK2029746T3
(da)
*
|
2006-06-12 |
2012-10-08 |
Exegenics Inc D B A Opko Health Inc |
Sammensætninger og fremgangsmåder til siRNA-hæmning af angiogenese
|
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
BRPI0714815A2
(pt)
*
|
2006-08-07 |
2013-05-21 |
Bausch & Lomb |
composiÇço, e, uso de um (a) agonista e (b) um agente anti-infeccioso
|
|
EP2397140A1
(en)
*
|
2006-08-31 |
2011-12-21 |
Bausch & Lomb Incorporated |
Compositions and methods for treating or preventing glaucoma or progression thereof
|
|
US7872118B2
(en)
*
|
2006-09-08 |
2011-01-18 |
Opko Ophthalmics, Llc |
siRNA and methods of manufacture
|
|
US20110105559A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
|
|
DK2061444T3
(da)
*
|
2006-09-11 |
2011-06-27 |
Bausch & Lomb |
Sammensætninger og fremgangsmåder til behandling, kontrol, reducering, forbedring eller forebyggelse af allergi
|
|
US20110104159A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
|
|
US20080145405A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Kunzler Jay F |
Drug delivery devices
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
BRPI0807571A2
(pt)
|
2007-02-22 |
2014-07-01 |
Othera Holding Inc |
Compostos de hidroxilamina e métodos de seu uso
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
US20090042936A1
(en)
*
|
2007-08-10 |
2009-02-12 |
Ward Keith W |
Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
|
|
US20090087443A1
(en)
|
2007-09-27 |
2009-04-02 |
Bartels Stephen P |
Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
|
|
JP5323845B2
(ja)
*
|
2007-10-05 |
2013-10-23 |
エシコン・インコーポレイテッド |
ヒト臍帯組織由来細胞を用いた腎組織の修復および再建
|
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
|
US9023062B2
(en)
*
|
2008-04-17 |
2015-05-05 |
Apollo Endosurgery, Inc. |
Implantable access port device and attachment system
|
|
US9023063B2
(en)
|
2008-04-17 |
2015-05-05 |
Apollo Endosurgery, Inc. |
Implantable access port device having a safety cap
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
AU2009322279A1
(en)
|
2008-12-04 |
2011-07-14 |
Opko Pharmaceuticals, Llc |
Compositions and methods for selective inhibition of pro-angiogenic VEGF isoforms
|
|
WO2010077732A2
(en)
*
|
2008-12-09 |
2010-07-08 |
Aether Medical Llc |
Implantable analgesic
|
|
BRPI0923177A2
(pt)
*
|
2008-12-19 |
2020-08-25 |
Advanced Technologies And Regenerative Medicine, Llc |
usos de composições para tratar dor neuropática e espacidade, as referidas composições, e kit
|
|
CN102387807A
(zh)
|
2008-12-19 |
2012-03-21 |
先进科技及再生医学有限责任公司 |
肺部疾病和病症的治疗
|
|
US10179900B2
(en)
*
|
2008-12-19 |
2019-01-15 |
DePuy Synthes Products, Inc. |
Conditioned media and methods of making a conditioned media
|
|
JP6095893B2
(ja)
*
|
2008-12-19 |
2017-03-15 |
デピュイ・シンセス・プロダクツ・インコーポレイテッド |
傷害後の神経組織の再生および修復
|
|
WO2010083035A2
(en)
|
2009-01-14 |
2010-07-22 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US9636255B2
(en)
|
2009-02-13 |
2017-05-02 |
Dose Medical Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
SG174551A1
(en)
*
|
2009-03-26 |
2011-10-28 |
Ethicon Inc |
Human umbilical cord tissue cells as therapy for alzheimer' s disease
|
|
US20110077270A1
(en)
*
|
2009-04-21 |
2011-03-31 |
Pfeffer Bruce A |
Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
|
|
US8632511B2
(en)
*
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
|
WO2015073571A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Dose Medical Corporation |
Ocular implants configured to store and release stable drug formulations
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
EP2432420A4
(en)
*
|
2009-05-18 |
2018-01-10 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
EP2437684B1
(en)
|
2009-06-03 |
2022-06-15 |
ForSight Vision5, Inc. |
Anterior segment drug delivery
|
|
IN2012DN00352A
(cs)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8708979B2
(en)
|
2009-08-26 |
2014-04-29 |
Apollo Endosurgery, Inc. |
Implantable coupling device
|
|
US8715158B2
(en)
|
2009-08-26 |
2014-05-06 |
Apollo Endosurgery, Inc. |
Implantable bottom exit port
|
|
US8506532B2
(en)
|
2009-08-26 |
2013-08-13 |
Allergan, Inc. |
System including access port and applicator tool
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
US8227444B2
(en)
*
|
2009-12-04 |
2012-07-24 |
Opko Ophthalmics, Llc |
Compositions and methods for inhibition of VEGF
|
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
WO2011079232A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
US20110189174A1
(en)
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
|
US8882728B2
(en)
|
2010-02-10 |
2014-11-11 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US20110270025A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Remotely powered remotely adjustable gastric band system
|
|
US20110270021A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Electronically enhanced access port for a fluid filled implant
|
|
US8992415B2
(en)
|
2010-04-30 |
2015-03-31 |
Apollo Endosurgery, Inc. |
Implantable device to protect tubing from puncture
|
|
EP2571526B1
(en)
*
|
2010-05-17 |
2019-03-13 |
Novaer Holdings, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
|
CA2803923A1
(en)
|
2010-06-25 |
2011-12-29 |
Ignacio R. Rodriguez |
Methods of treatment using sterculic acid
|
|
CN103209664A
(zh)
|
2010-08-05 |
2013-07-17 |
弗赛特影像4股份有限公司 |
可植入的治疗装置
|
|
EP3861969A1
(en)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
US20120041258A1
(en)
|
2010-08-16 |
2012-02-16 |
Allergan, Inc. |
Implantable access port system
|
|
US20120065460A1
(en)
|
2010-09-14 |
2012-03-15 |
Greg Nitka |
Implantable access port system
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
EP2654715B1
(en)
|
2010-11-24 |
2017-01-25 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
WO2012080833A2
(en)
|
2010-12-13 |
2012-06-21 |
Purdue Pharma L.P. |
Controlled release dosage forms
|
|
US8821373B2
(en)
|
2011-05-10 |
2014-09-02 |
Apollo Endosurgery, Inc. |
Directionless (orientation independent) needle injection port
|
|
US20120316199A1
(en)
|
2011-06-07 |
2012-12-13 |
Ward Keith W |
Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
US8801597B2
(en)
|
2011-08-25 |
2014-08-12 |
Apollo Endosurgery, Inc. |
Implantable access port with mesh attachment rivets
|
|
EP3290024B1
(en)
|
2011-08-29 |
2019-04-17 |
Mati Therapeutics Inc. |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
|
JP5989780B2
(ja)
|
2011-09-14 |
2016-09-07 |
フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． |
眼挿入装置および方法
|
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
|
CA2856703A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US9199069B2
(en)
|
2011-10-20 |
2015-12-01 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US8858421B2
(en)
|
2011-11-15 |
2014-10-14 |
Apollo Endosurgery, Inc. |
Interior needle stick guard stems for tubes
|
|
US9089395B2
(en)
|
2011-11-16 |
2015-07-28 |
Appolo Endosurgery, Inc. |
Pre-loaded septum for use with an access port
|
|
WO2013082000A1
(en)
|
2011-11-30 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
AU2012346537A1
(en)
|
2011-12-01 |
2014-07-17 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
AU2012358810B2
(en)
|
2011-12-23 |
2018-03-15 |
DePuy Synthes Products, Inc. |
Detection of human umbilical cord tissue-derived cells
|
|
US10028824B2
(en)
|
2012-01-24 |
2018-07-24 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
EP2806828B1
(en)
|
2012-01-24 |
2021-07-21 |
The Regents of The University of Colorado, A Body Corporate |
Modular intraocular lens designs and methods
|
|
US9364316B1
(en)
*
|
2012-01-24 |
2016-06-14 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US10080648B2
(en)
|
2012-01-24 |
2018-09-25 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
KR101969594B1
(ko)
*
|
2012-05-11 |
2019-04-16 |
서강대학교산학협력단 |
안내 약물 전달 임플란트
|
|
RU2652063C2
(ru)
|
2012-10-26 |
2018-04-24 |
Форсайт Вижн5, Инк. |
Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
|
|
WO2014164703A1
(en)
|
2013-03-11 |
2014-10-09 |
University Of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for occular inflammation
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
|
WO2014179568A2
(en)
|
2013-05-02 |
2014-11-06 |
Odin Biotech |
Two-layer ocular implant
|
|
EP3068372B1
(en)
*
|
2013-11-14 |
2019-05-08 |
EyeD Pharma |
Eye device
|
|
AU2015219461B2
(en)
|
2014-02-18 |
2019-10-31 |
Alcon Inc. |
Modular intraocular lens designs, tools and methods
|
|
AU2015266850B2
(en)
|
2014-05-29 |
2019-12-05 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US9580896B2
(en)
|
2014-07-05 |
2017-02-28 |
John David Hopkins |
Apparatus and method for prolonged active agent in aqueous systems
|
|
ES2803102T3
(es)
|
2014-07-15 |
2021-01-22 |
Forsight Vision4 Inc |
Dispositivo de administración de implante ocular
|
|
RU2017105844A
(ru)
|
2014-08-08 |
2018-09-11 |
Форсайт Вижн4, Инк. |
Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения
|
|
CN110478119B
(zh)
|
2014-11-10 |
2022-04-15 |
弗赛特影像4股份有限公司 |
可膨胀药物递送装置和使用方法
|
|
EP3250152B1
(en)
|
2015-01-30 |
2025-03-12 |
Alcon Inc. |
Inserter for inserting a base and a lens of a modular intraocular lens into an eye
|
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
US11458041B2
(en)
|
2015-10-08 |
2022-10-04 |
Ocular Therapeutix, Inc. |
Punctal plug and bioadhesives
|
|
CN108348327B
(zh)
|
2015-11-04 |
2021-10-01 |
克拉维斯塔医疗有限公司 |
模块化人工晶状体设计、工具和方法
|
|
WO2017087902A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
|
CN113017981B
(zh)
|
2016-04-05 |
2023-07-25 |
弗赛特影像4股份有限公司 |
药物递送装置
|
|
AU2017252294B2
(en)
|
2016-04-20 |
2021-12-02 |
Glaukos Corporation |
Bioresorbable ocular drug delivery device
|
|
US11045309B2
(en)
|
2016-05-05 |
2021-06-29 |
The Regents Of The University Of Colorado |
Intraocular lens designs for improved stability
|
|
CA3029997A1
(en)
|
2016-07-05 |
2018-01-11 |
Janssen Biotech, Inc. |
Treatment of retinal vascular disease using progenitor cells
|
|
EP4537830A3
(en)
|
2017-06-13 |
2025-06-11 |
EyePoint Pharmaceuticals, Inc. |
Bioerodible drug delivery devices
|
|
US11382736B2
(en)
|
2017-06-27 |
2022-07-12 |
Alcon Inc. |
Injector, intraocular lens system, and related methods
|
|
US11103460B2
(en)
|
2017-08-07 |
2021-08-31 |
Board Of Regents, The University Of Texas System |
Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
|
|
CN111655206B
(zh)
|
2017-11-21 |
2022-10-14 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
EP3803866A4
(en)
|
2018-05-24 |
2022-03-16 |
Nureva Inc. |
METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
|
|
KR20260007295A
(ko)
|
2018-05-24 |
2026-01-13 |
셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 |
거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
|
|
MX2020012459A
(es)
|
2018-05-24 |
2021-04-28 |
Celanese Eva Performance Polymers Llc |
Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
|
|
US11779739B2
(en)
*
|
2018-12-21 |
2023-10-10 |
Perfect Ip, Llc |
Drug delivery system and method
|
|
AU2020233396B2
(en)
|
2019-03-04 |
2025-09-11 |
Duke University |
Compositions and methods for the diagnosis and treatment of retinopathies
|
|
PT3861985T
(pt)
|
2020-02-06 |
2023-08-03 |
Ocular Therapeutix Inc |
Composições e métodos para tratar doenças oculares
|
|
AU2021225926A1
(en)
|
2020-02-26 |
2022-10-20 |
Case Western Reserve University |
Compositions and methods for treating misfolded protein ocular disorders
|
|
PT3884929T
(pt)
|
2020-03-25 |
2023-08-09 |
Ocular Therapeutix Inc |
Implante ocular contendo um inibidor da tirosina cinase
|
|
EP4142664A4
(en)
|
2020-04-27 |
2024-05-29 |
Ocular Therapeutix, Inc. |
METHODS FOR TREATING ALLERGIC CONJUNCTIVITIS
|
|
EP4216929A1
(en)
|
2020-09-24 |
2023-08-02 |
Ocular Therapeutix, Inc. |
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent
|
|
EP3973952B1
(en)
|
2020-09-24 |
2024-02-14 |
Ocular Therapeutix, Inc. |
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
|
|
BR112023022439A2
(pt)
|
2021-04-26 |
2023-12-26 |
Celanese Eva Performance Polymers Llc |
Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
|
|
US11357620B1
(en)
|
2021-09-10 |
2022-06-14 |
California LASIK & Eye, Inc. |
Exchangeable optics and therapeutics
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
PE20260040A1
(es)
|
2023-04-11 |
2026-01-09 |
Ocular Therapeutix Inc |
Implante ocular que contiene un inhibidor de la tirosina cinasa
|